Dr. Sidney Wolfe, director of the Health Research Group -- part of the nonprofit consumer advocacy organization Public Citizen -- isn't hopeful about the development of an effective and safe weight-loss drug.
Yesterday, Orexigen, which seemed to have abandoned its obesity drug Contrave after the Food and Drug Administration asked for a giant study to prove the medicine is safe, jumped back in the weight-loss game .